Literature DB >> 6190599

Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens?

C C Bernard, E Townsend, V B Randell, H G Williamson.   

Abstract

Immunological activity to various antigens, including brain components, measles and other viruses, has been associated with IgG in multiple sclerosis (MS). One possible explanation for the presence of anti-viral antibodies and antibody to myelin basic protein (MBP) in MS patients is that there are antigenic determinants common to certain viruses and MBP. To assess this possibility, IgG from individual brains and sera from patients with MS, subacute sclerosing panencephalitis (SSPE) and controls was isolated by protein A and MBP-Sepharose affinity chromatography. Antibody to MBP was measured with a solid phase radioimmunoassay and antibody to measles and other viruses by immunofluorescence and/or complement fixation. Anti-MBP activity was detected in brain extracts and sera of all MS patients tested. In contrast to the low levels of antibody to MBP in control brains, high levels of anti-MBP antibodies were found in most of the normal sera. There was no correlation between the presence and levels of serum anti-measles antibodies and the anti-MBP activity. None of the anti-MBP antibodies affinity purified from brain and serum of MS patients reacted with any of the viruses tested, including measles. IgG purified from SSPE patients or from a rabbit hyperimmunized with measles antigen had no reactivity to MBP, despite high levels of anti-measles antibody. It is concluded that there is not direct link between the presence of antibody to MBP and antibody to measles and other viruses in MS patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190599      PMCID: PMC1535590     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

Review 1.  Pathology of the early lesion in multiple sclerosis.

Authors:  J Prineas
Journal:  Hum Pathol       Date:  1975-09       Impact factor: 3.466

2.  Multiple sclerosis: local synthesis of electrophoretically restricted measles, rubella, mumps and herpes simplex virus antibodies in the central nervous system.

Authors:  H J Nordal; B Vandvik; E Norrby
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

3.  The 1976 influenza epidemic in Melbourne.

Authors:  A Donaldson; F A Lewis; M L Kennett; J White; I D Gust
Journal:  Med J Aust       Date:  1978-07-15       Impact factor: 7.738

4.  Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination.

Authors:  C F Brosnan; G L Stoner; B R Bloom; H M Wisniewski
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

5.  Measles-virus antibody and antigen in subacute sclerosing panencephalitis.

Authors:  J H Connolly; I V Allen; L J Hurwitz; J H Millar
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

6.  Immunoglobulin synthesis in vitro by cerebrospinal fluid cells in patients with multiple sclerosis.

Authors:  M Sandberg-Wollheim
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

7.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

8.  Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system.

Authors:  M M Esiri
Journal:  Neuropathol Appl Neurobiol       Date:  1980 Jan-Feb       Impact factor: 8.090

9.  Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis.

Authors:  B Vandvik; E Norrby; H J Nordal; M Degré
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

10.  CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  H S Panitch; C J Hooper; K P Johnson
Journal:  Arch Neurol       Date:  1980-04
View more
  5 in total

1.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study.

Authors:  O Andersen; P E Lygner; T Bergström; M Andersson; A Vahlne
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

2.  Are there altered antibody responses to measles, mumps, or rubella viruses in autism?

Authors:  Jane E Libbey; Hilary H Coon; Nikki J Kirkman; Thayne L Sweeten; Judith N Miller; Janet E Lainhart; William M McMahon; Robert S Fujinami
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

3.  Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

4.  Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

Authors:  J L McQualter; R Darwiche; C Ewing; M Onuki; T W Kay; J A Hamilton; H H Reid; C C Bernard
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

Review 5.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.